AMANDA CALDWELL: Open Payments
NPI 1871954552 · LEAWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$99,617 in 276 payments from 21 companies in 2025. Trend: 2023 $33,062 · 2024 $61,763 · 2025 $99,617
Speaker / faculty: $77,913Travel & lodging: $12,498Food & beverage: $5,415Consulting: $3,690Education: $101
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 43 | $40,571 |
| Galderma Laboratories, L.P. | 55 | $37,334 |
| Amgen Inc. | 25 | $13,311 |
| Regeneron Healthcare Solutions, Inc. | 26 | $4,553 |
| Regeneron Pharmaceuticals, Inc. | 4 | $1,107 |
| ABBVIE INC. | 36 | $513 |
| UCB, Inc. | 11 | $417 |
| GENZYME CORPORATION | 4 | $264 |
| LEO Pharma Inc. | 13 | $254 |
| E.R. Squibb & Sons, L.L.C. | 8 | $247 |
Products named: TREMFYA, NEMLUVIO, DUPIXENT, Bimzelx, RINVOQ, OTEZLA, Sotyktu, OPZELURA.
Industry payments across KS — which companies pay providers there.
